期刊名称:JOURNAL OF PROTEOMICS
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
![Journal of Proteomics on ScienceDirect(Opens new window)](http://www.elsevier.com/framework_products/images/51/713351.gif)
The Journal of Proteomics covers all areas of applied and basic research in Proteomics using multi-disciplinary approaches to unravel biological processes. Emphasis is placed on translational research and biomarker discovery in human, animal, micro-organism and plant systems. The journal provides a forum for activities in proteomics and helps strengthen the links between research scientists all over the world.
In addition to original papers, the journal welcomes state-of-the-art reviews and update papers, letters to the editor, book reviews, reports and news, as well as Proceedings of EuPA national congresses. The journal also publishes the official EuPA guidelines papers.
Coverage: Original articles, state-of-the-art reviews, technical notes, editorials, news & views (commentary, science policy issues, ethical and legal issues, education, industry needs and alliances, regulatory issues, news items), letters to the editor, conference announcements, advertisements.
Submitting Authors: Manuscripts can be submitted to Journal of Proteomics at http://ees.elsevier.com/jprot/
Instructions to Authors The Journal of Proteomics covers all areas of applied and basic research in Proteomics using multi-disciplinary approaches to unravel biological processes. Emphasis is placed on translational research and biomarker discovery in human, animal, micro-organism and plant systems. The journal provides a forum for activities in proteomics and helps strengthen the links between research scientists all over the world.
In addition to original papers, the journal publishes frequent review and update papers, letters to the editor, book reviews, reports and news as well as Proceedings of EuPA national congress. The journal also publishes the official EuPA guidelines papers.
The following types of paper are published:
Original Articles: Original articles are the normal medium of publication. Although there is no fixed length, articles should be as concise as possible, while providing sufficient information for the work to be repeated and for the claims of the authors to be judged by the readers.
Reviews: These are contributed by scientists who are leading specialists in their field of expertise, normally at the invitation of the Editors. Authors wishing to contribute a review paper are advised first to contact one of the responsible Editors (listed in the issues of Journal of Proteomics to avoid overlap with Reviews already commissioned.)
Technical reports: Technical reports should present brief descriptions of novel apparatus, a new experimental or computational method, test or procedure, or an improvement or noteworthy modification of an already existing technique or platform used in the proteomic workflow. Technical reports should show a realistic application of the methodology described. Theoretical papers dealing with mechanistic aspects of proteomic techniques will also be considered. A technical report should be a short (no more than two pages when published) description written in a continuous style with no more than two figures and one table.
News & Views: News & Views point out the author(s) vision of the character and importance of a new direction in proteome research. They are not intended to be accounts or analyses of an individual's personal research. Although News & Views will usually be invited, they can be submitted without invitation. Author(s) are encouraged to suggest experts in the field who can act as reviewers.
Letters to the Editor: Letters to the Editor are intended to stimulate discussion and debate in areas of general concern and controversy in proteomics, and generally reflect the personal opinions of the author(s). They should be written in a continuous style and should normally not exceed two printed pages and contain no more than one figure or table.
Types of paper
Page charges
This journal has no page charges.
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/ethicalguidelines.
Policy and ethics
The work described in your article must have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/e/policy/b3.htm; EC Directive 86/609/EEC for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated at an appropriate point in the article.
Animal experiments Where animals have been used in a study, the institutional ethical or animal welfare Authority under which the work was conducted must be stated, along with the specific authorisation reference number. Circumstances relating to animal experimentation must meet the International Guiding Principles for Biomedical Research Involving Animals, as issued by the Council for the International Organizations of Medical Sciences. These guidelines are obtainable from: Executive Secretary C.I.O.M.S., c/o WHO, Appia, CH-1211 Geneva 27, Switzerland, or at the following URL: http://www.cioms.ch/frame_1985_texts_of_guidelines.htm.
The Journal of Proteomics will reject any paper where there is reason to believe that animals have been subjected to unnecessary or avoidable pain or distress.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Sponsored articles
This journal offers you the choice of making your article freely available to all on Elsevier's electronic publishing platforms. The charge for article sponsorship is $3,000, which is necessary to offset publishing costs. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been accepted for publication. Full details of the sponsored Open Access options available to you and your funding body can be found here: http://www.elsevier.com/locate/sponsoredarticles. Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. More information can be found here: http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/languageediting or our customer support site at http://epsupport.elsevier.com for more information.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
Please provide the names and addresses of 4 - 5 suitable potential reviewers. If there are compelling reasons for excluding some individuals as potential reviewers, these can be mentioned. However, choice of reviewers is at the Editors' discretion.
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Do not import the figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on Electronic illustrations. To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions of your wordprocessor.
To assist in the reviewing of your paper, please add line numbering to your manuscript file
Article Structure
Original articles are usually divided into the sections Introduction, Materials and methods, Results, Discussion and Conclusions:
Introduction This is a short section in which the authors should state the reasons for performing the work, with brief reference to relevant previous work.
Material and methods Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results Results should be clear and concise.
Discussions This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
(Technical reports, News & Views, Letters to the Editor: These types of papers are not divided into sections after the summary, except for the reference list. The first paragraph serves as an introduction; acknowledgments are added as a final paragraph before the reference list.)
Experimental design data analysis for 2-D PAGE and MS-based experiments: The experimental design must be provided and must include details of the number of biological and analytical replicates. Only one biological/analytical replicate will not be acceptable. In clinical studies, it is highly desirable that a power analysis predicting the appropriate sample size for subsequent statistical analysis of the data is carried out.
For expression analysis studies, summary statistics (mean, standard deviation) must be provided and results of statistical analysis must be shown. Reporting fold differences alone is not acceptable.
Authors must report the following: methods of data normalization, transformation, missing value handling, the statistical tests used, the degrees of freedom and the statistical package or program used. Where biologically important differences in protein (gene) expression are reported, confirmatory data (e.g. from Western blot, RT-PCR analysis, etc.) are desirable. For biomarker discovery/validation studies, the sensitivity and specificity of the biomarker(s) should be provided wherever possible. It is desirable that receiver operator characteristic (ROC) curves and areas under the curves are given. The method(s) used to generate the mass spectrometry data must be described. The name and version of the program used for database searching, the values of critical search parameters (e.g. the mass over charge (m/z) and the charge (z) of the precursor ion, fragment mass tolerance, cleavage rules used, allowance for number of missed cleavages and modifications) and the name and version of the database(s) searched must be provided. For each protein identified, measures of certainty (e.g. p-values) must be provided. For MS/MS, the number of peptides used to identify a protein must be given as well as the sequence and charge state of each peptide.
Identification of proteins based solely on mass fingerprinting will be considered only if the sequence of the genome of the organism under study is known. For peptide mass fingerprinting, the number of peptides that match the sequence, the number of unmatched peaks, and the total percent of sequence coverage must be quoted. If extensive, the above information should be submitted as Supplemental Information (see below). In order to reduce the possibility of false-positive hits, whenever possible, authors are advised to verify the mass fingerprint assignment of at least one peptide ion by MS/MS sequencing.
Identification of proteins from organisms with unknown genome sequence will be accepted only if MS/MS-derived peptide sequence data have been used for database searching or BLAST analysis. The score for the highest ranked hit to an homologous, orthologous, or paralogous protein should be indicated.
For experiments with large MS/MS data sets, estimates of the false positive rates are required (e.g. through searching randomized or reversed sequence databases). This information should be provided as supporting information. Where post-translational modifications are reported, the methods used to discover the modification must be described. The modification should be mapped to amino acid(s) by fragmentation analysis, but reported as ambiguous if mapping to a single amino acid is not possible. For isobaric modifications, evidence for assigning a specific modification must be provided and the spectra included as supporting information. Where protein sequence isoforms are reported, the peptide sequence that matches the unique amino acid sequence of a particular isoform must be provided. Fragmentation analysis of the appropriate peptides should be described.
Graphical Abstract A Graphical Abstract should allow readers to quickly gain an understanding of the main take-home message of the paper and is intended to encourage browsing, promote interdisciplinary scholarship, and help readers identify more quickly which papers are most relevant to their research interests. The Graphical Abstract should summarize the contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership. Authors must provide images that clearly represent the work described in the paper. A key, summarising figure taken from the original paper can also be submitted as a graphical abstract.
Graphical Abstracts should be submitted as a separate file in EES by selecting "Graphical Abstract" from the drop-down box when uploading files.
Specifications: maximum image size 400x600 pixels (height x width, recommended size 200 x 500 pixels) using Arial font with a size of 10-16 points; preferred file types TIFF, EPS, PDF or MS Office files. A Graphical abstract should be one image file and should not contain multiple panels; visualize one process or make one point clear; for ease of browsing, images should have a clear start and end, preferably "reading" from top to bottom or left to right; try to reduce distracting and cluttering elements as much as possible.
The graphical abstract will be displayed in online search result lists, the Contents List and the online article, but will not appear in the article PDF file or print.
Research highlights
Research highlights are a short collection of bullet points that convey the core findings of the article. Research highlights are optional and should be submitted in a separate file in the online submission system. Please use 'Research highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters per bullet point including spaces). See http://www.elsevier.com/researchhighlights for examples.
Accession numbers
Accession numbers are unique identifiers in bioinformatics allocated to nucleotide and protein sequences to allow tracking of different versions of that sequence record and the associated sequence in a data repository [e.g., databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine ('GenBank') and the Worldwide Protein Data Bank]. There are different types of accession numbers in use based on the type of sequence cited, each of which uses a different coding. Authors should explicitly mention the type of accession number together with the actual number, bearing in mind that an error in a letter or number can result in a dead link in the online version of the article. Please use the following format: accession number type ID: xxxx (e.g., MMDB ID: 12345; PDB ID: 1TUP). Note that in the final version of the electronic copy, accession numbers will be linked to the appropriate database, enabling readers to go directly to that source from the article.
Artwork
Electronic artwork
General points • Make sure you use uniform lettering and sizing of your original artwork. • Save text in illustrations as "graphics" or enclose the font. • Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol. • Number the illustrations according to their sequence in the text. • Use a logical naming convention for your artwork files. • Provide captions to illustrations separately. • Produce images near to the desired size of the printed version. • Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions You are urged to visit this site; some excerpts from the detailed information are given here. Formats Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below): EPS: Vector drawings. Embed the font or save the text as "graphics". TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi. TIFF: Bitmapped line drawings: use a minimum of 1000 dpi. TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required. DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is". Please do not: • Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document; • Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low; • Supply files that are too low in resolution; • Submit graphics that are disproportionately large for the content.
Color artwork Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For further information on the preparation of electronic artwork, please see Please note: Because of technical complications which can arise by converting color figures to "gray scale" (for the printed version should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
References
Citaiton in Text
The numerical system of references should be used. References in the text should be cited by numbers in square brackets in the order of their citation.
References are listed together in their order of appearance in a separate section at the end of the text under the heading References. All references should be numbered consecutively. References to journals should contain initials and names of all authors, article title, abbreviation of the name of the journal according to the List of Serial Title World Abbreviations (International Series Data System, 20, rue Bachaumont, 75002 Paris, France. ISBN 2-904938-02-8), year of publication, volume number, and page numbers. References to books should also include the title (of series and volumes), initials and names of the editor(s), the publisher and place of publication.
Examples:
Reference to a journal publication: [1] Resing KA, Ahn NG. Proteomics strategies for protein identification. FEBS Letters 2005;579:885-9.
Reference to a book: [2] Rehm H. Protein Biochemistry and Proteomics. San Diego: Academic Press/Elsevier Inc; 2006.
Reference to a chapter in an edited book or book series: [3] Morgan JW, Hettick JM, Russell DH. Peptide sequencing by MALDI 193-nm photodissociation TOF MS. In: Burlingame AL, editor. Methods in Enzymology, vol 402: Biological Mass Spectrometry. San Diego: Academic Press/Elsevier Inc; 2005, p.186-209.
Reference to a paper as "in press" implies that it has been accepted for publication. Evidence (e.g., a photocopy of the note of acceptance from the journal concerned) should accompany the submitted typescript. Papers that are "in press" should be included as a number in the text. Other papers submitted before or simultaneously with the paper in question should be included as a number in the text and in the References section, stating the name of the journal. Copies of papers that are submitted elsewhere should be provided for inspection by the Editors. Omission of this information will delay publication and may lead to redating of a submitted manuscript. Papers presented at scientific meetings that are not available in published form should not be cited as references in the References section.
Unpublished results should not be listed in the References section. In the text they are mentioned as follows: "(Tervoort MV and Glimcher J, unpublished data)". When unpublished results are cited, the data should be provided for the Editors' information when essential for proper evaluation, or if requested.
A personal communication should be mentioned in the text as follows: "(Tervoort MV, personal communication)". Authors should not make unauthorized use of personal communications. Personal communications are not to be included in the Reference section.
Reference management software This journal has standard templates available in key reference management packages EndNote ( http://www.endnote.com) and Reference Manager ( http://www.refman.com). Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style which is described below.
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a maximum size of 10 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.
Supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item. Ensure that the following items are present: One Author designated as corresponding Author: • E-mail address • Full postal address • Telephone and fax numbers All necessary files have been uploaded • Keywords • All figure captions • All tables (including title, description, footnotes) Further considerations • Manuscript has been "spellchecked" and "grammar-checked" • References are in the correct format for this journal • All references mentioned in the Reference list are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Web) • Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print • If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes For any further information please visit our customer support site at http://epsupport.elsevier.com.
• Line numbers have been added to your manuscript file
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
Appendix
Standard abbreviations allowed to be used without explanation or definition in all articles published in the Journal of Proteomics.
A absorbance ACES 2-[(2-amino-2-oxoethyl)amino] ethanesulphonic acid CAN acetonitrile A/D analog to digital converter AEBSF 4-(2-aminoethyl)benzenesulphonyl fluoride amu atomic mass unit ANOVA analysis of variance API atmospheric pressure ionization AUC area under curve Bis N,N'-methylenebisacrylamide bp base pairs BSA bovine serum albumin %C cross-linking agent (g/100 mL)/%T CAPS 3-(cyclohexylamino)-1-propanesulphonic acid CBB Coomassie Brilliant Blue CCD charge-coupled device CD circular dicroism CE capillary electrophoresis CEC capillary electrochromatography CFE continuous flow electrophoresis CHAPS 3-[(3-cholamidopropyl)dimethylamonio]-1-propanesulphonate CHCA α-cyano-4-hydroxycinnamic acid CHES 2-(N-cyclohexylamino)ethanesulphonic acid CID collision-induced dissociation CIEF capillary isoelectric focusing CMC critical micelle concentration Con A Concanavalin A CNS central nervous system cpm counts per minute CTAB etyltrimethylammonium bromide CV coefficient of variation CZE capillary zone electrophoresis 1-D one-dimensional 2-D two-dimensional Da dalton (molecular mass) 2-DE two-dimensional electrophoresis DIGE fluorescence difference gel electrophoresis DGGE denaturing gradient gel electrophoresis DMEM Dulbecco's modified Eagle medium DMF N,N-dimethylformamide DMSO dimethyl sulphoxide DOC sodium deoxycholate dsDNA double-stranded DNA DTE dithioerithriol DTT dithiothreitol ECL enhanced chemiluminescence EDTA ethylenediaminetetraacetic acid EEO electroendosmosis EGTA ethylene glycol-bis(β-aminoethylether)-N,N,N',N'-tetraacetic acid EKC electrokinetic chromatography ELISA enzyme-linked immunosorbent assay EMSA electrophoretic mobility shift assay EOF electroosmotic flow ER endoplasmic reticulum ESI electrospray ionization EST expressed sequence tag EUPA European Proteome Association FAB fast atom bombardment FACS fluorescence activated cell sorting FBS fetal bovine serum FCS fetal calf serum FIGE field inversion gel electrophoresis FITC fluorescein isothiocyanate FT Fourier transform FT-ICR Fourier transform-ion cyclotron resonance GC gas chromatography GIF graphic interchange format GRAVY grand average hydrophobicity GSH glutathione GST glutathione-S-transferase HE hematoxylin and eosin HEPES N-(2-hydroxyethyl)piperazine-2'-(2-ethanesulphonic acid) HPCE high-performance capillary electrophoresis HPLC high-performance liquid chromatography HRP horseradish peroxidase HSA human serum albumin HSP heat shock protein HTML hypertext mark-up language HUPO Human Proteome Organisation HVR hypervariable region ICAT isotop-coded affinity tag ICR ion cyclotron resonance id inside diameter IEF isoelectric focusing Ig immunoglobulin IMAC immobilized metal affinity capture IPG immobilized pH gradient IT ion trap iTRAQ isobaric tag for relative and absolute quantitation kbp kilobase pairs kDa kilodalton (molecular mass) LC liquid chromatography LED light-emitting diode LOD limit of detection LOQ limit of quantitation mAb monoclonal antibody MALDI-MS matrix-assisted laser-desorption ionization-mass spectrometry Mbp megabase
MEKC micellar electrokinetic capillary chromatography MES 2-(N-morpholino)ethanesulphonic acid MHC major histocompatibility complex MOPS 3-(N-morpholino)propanesulphonic acid Mr relative molecular mass (dimensionless) MS mass spectrometry MS/MS tandem mass spectrometry MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide m/z mass-to-charge ratio NC nitrocellulose NEPHGE nonequilibrium pH gradient electrophoresis NMR nuclear magnetic resonance NP-40 Nonidet P-40 od outside diameter OD optical density OFAGE orthogonal field alternation gel electrophoresis ORF open reading frame PAGE polyacrylamide gel electrophoresis PBS phosphate-buffered saline PCR polymerase chain reaction PDMS polydimethylsiloxane PED pulsed electrochemical detection PEG polyethylene glycol PFGE pulsed-field gel electrophoresis PFU plaque-forming units pI isoelectric point PMF peptide mass fingerprinting PMS phenazine methosulphate PMSF phenylmethylsulphonyl fluoride PMT photomultiplier tube PSD post-source decay PTFE polytetrafluoroethylene PTH phenylthiohydantoin PTM post-translational modification PVA polyvinyl alcohol PVDF polyvinylidene difluoride PVP polyvinylpyrrolidone Q-TOF quadrupole time-of-flight RACE rapid amplification of cDNA ends RFLP restriction fragment length polymorphism RIA radioimmunoassay ROS reactive oxygen species RP reversed phase rpm revolutions per minute RSD relative standard deviation RT-PCR reverse transcriptase-PCR SAGE serial analysis of gene expression SD standard deviation SDS sodium dodecyl sulphate SEC size-exclusion chromatography SELDI surface-enhanced laser desorption/ionization SEM standard error of the mean SIM selected ion monitoring S/N signal-to-noise ratio SPE solid-phase extraction SPR surface plasmon resonants SSCP single-strand conformation polymorphism ssDNA single-stranded DNA SSP sample spot number STR short tandem repeat %T total gel concentration (acrylamide plus cross-linking agent; g/100 mL) TBS Tris-buffered saline TCA trichloroacetic acid TEMED N,N,N',N'-tetramethylethylenediamine TFA trifluoroacetic acid THF tetrahydrofuran TIC total ion current TLC thin-layer chromatography TNF tumour necrosis factor TOF time of flight Tris tris(hydroxymethyl)aminomethane TRITC tetramethylrhodamine isothiocyanate URL uniform resource locator UTR untranslated region UV ultraviolet Vh volt ×hours z ion charge
For inquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Editorial Board
Editor in Chief:
J.J. Calvete
Valencia, Spain
Executive Editors:
Proteomics in Cell Biology
J.-J. Diaz
LYON cedex 08, France
Proteomics in Microbiology:
C. Gil
Madrid, Spain
Proteomics in Plant Systems:
J.V. JorrÃn-Novo
Córdoba, Spain
Proteomics in Protein Science:
J. Peter-Katalinic
Münster, Germany
Biomedical Applications of Proteomics and Congress Proceedings:
J.-C. Sanchez
Geneva, Switzerland
Proteomics of Body Fluids and Proteomic Technologies:
P.G. Righetti
Milan, Italy
Bioinformatics in Proteomics:
P. Højrup
Odense, Denmark
Animal Proteomics
I. Miller
Vienna, Austria
Editorial Board .pdf
|